Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques (Q44506505)

3 December 2017

Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques (English)

1 reference

3 December 2017

5

David Montefiori

1 reference

3 December 2017

Ussama M Abdel-Motal

1

1 reference

3 December 2017

Jacqueline Gillis

2

1 reference

3 December 2017

Kelledy Manson

3

1 reference

3 December 2017

Michael Wyand

4

1 reference

3 December 2017

Kelly Stefano-Cole

6

1 reference

3 December 2017

Ronald C Montelaro

7

1 reference

3 December 2017

John D Altman

8

1 reference

3 December 2017

R Paul Johnson

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

3 December 2017

1 reference

3 December 2017

333

1 reference

3 December 2017

226-238

1 reference

3 December 2017

2

1 reference

Immunological memory and protective immunity: understanding their relation

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Functional differences between memory and naive CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Accessing complexity: the dynamics of virus-specific T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

An African primate lentivirus (SIVsm) closely related to HIV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Protective immunity induced by live attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Cytotoxic T-cell memory without antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.030

7 January 2021

10.1016/J.VIROL.2004.12.030

Identifiers

DOI

1 reference

3 December 2017

1 reference